Skip to main
PAYS

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign is expected to continue its growth trajectory, supported by its solid financial position and strategic acquisitions, as well as its innovative solutions and expansion plans. Despite facing competition and regulatory challenges, the company has consistently achieved strong financial performance and has the potential for further growth in the future. The company's strong focus on the healthcare industry and its market share gains make it a promising investment opportunity for the long term, but potential risks must be considered.

Bears say

PaySign is maintaining a strong revenue growth with a promising pipeline of new pharma campaigns, representing a 72% Y/Y increase. Their updated guidance for 2027 includes a 38%-40% increase in total revenue and a 98%-108% increase in adjusted EBITDA, showcasing their positive momentum and potential for future profits. However, the company's current enterprise value of approximately 15 times their 2027 adjusted EBITDA forecast is concerning and may reflect an overvaluation of the stock.

PaySign Inc (PAYS) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 3 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.